Source-grounded facts extracted from CONSTELLIUM SE's SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
CONSTELLIUM SE shareholders approved Authorization to be given to the Board of Directors for the repurchase by the Company of its own shares in accordance with article L. 225-209-2 of the French Commercial Code at the 2026-05-21 meeting.
“13. Authorization to be given to the Board of Directors for the repurchase by the Company of its own shares in accordance with article L. 225-209-2 of the French Commercial Code Voted For Voted Against Abstained 108,617,538 23,922 165,280”
CONSTELLIUM SE shareholders approved Approval of the aggregate maximum amount of the directors’ annual fixed fees at the 2026-05-21 meeting.
“12. Approval of the aggregate maximum amount of the directors’ annual fixed fees Voted For Voted Against Abstained Broker Non-Votes* 98,208,852 41,092 93,912 10,462,884”
CONSTELLIUM SE shareholders approved Discharge (quitus) of the directors, the Chief Executive Officer, and the Statutory Auditors of the Company in respect of the performance of their duties for the fiscal year ended December 31, 2025 at the 2026-05-21 meeting.
“10. Discharge (quitus) of the directors, the Chief Executive Officer, and the Statutory Auditors of the Company in respect of the performance of their duties for the fiscal year ended December 31, 2025 Voted For Voted Against Abstained Broker Non-Votes* 84,508,508 13,015,971 819,377 10,462,884”
CONSTELLIUM SE shareholders approved Approval of the consolidated financial statements and transactions for the fiscal year ended December 31, 2025 at the 2026-05-21 meeting.
“9 Approval of the consolidated financial statements and transactions for the fiscal year ended December 31, 2025 Voted For Voted Against Abstained 107,958,765 8,373 839,602”
CONSTELLIUM SE shareholders approved Approval of the statutory financial statements and transactions for the fiscal year ended December 31, 2025 at the 2026-05-21 meeting.
“8. Approval of the statutory financial statements and transactions for the fiscal year ended December 31, 2025 Voted For Voted Against Abstained 107,959,981 8,556 838,203”
CONSTELLIUM SE shareholders rejected Advisory (non-binding) vote to hold an advisory (non-binding) vote on the compensation of the Company’s named executive officers every three years at the 2026-05-21 meeting.
“7. Advisory (non-binding) vote to hold an advisory (non-binding) vote on the compensation of the Company’s named executive officers every three years Voted For Voted Against Abstained Broker Non-Votes* 2,195,685 95,903,685 244,486 10,462,884”
CONSTELLIUM SE shareholders rejected Advisory (non-binding) vote to hold an advisory (non-binding) vote on the compensation of the Company’s named executive officers every two years at the 2026-05-21 meeting.
“6. Advisory (non-binding) vote to hold an advisory (non-binding) vote on the compensation of the Company’s named executive officers every two years Voted For Voted Against Abstained Broker Non-Votes* 2,204,018 95,895,777 244,061 10,462,884”
CONSTELLIUM SE shareholders approved Advisory (non-binding) vote to hold an advisory (non-binding) vote on the compensation of the Company’s named executive officers every year at the 2026-05-21 meeting.
“5. Advisory (non-binding) vote to hold an advisory (non-binding) vote on the compensation of the Company’s named executive officers every year Voted For Voted Against Abstained Broker Non-Votes* 98,273,291 31,220 39,345 10,462,884”
CONSTELLIUM SE shareholders approved Approval, on an advisory (non-binding) basis, of the 2025 compensation of the Company’s named executive officers at the 2026-05-21 meeting.
“4. Approval, on an advisory (non-binding) basis, of the 2025 compensation of the Company’s named executive officers Voted For Voted Against Abstained Broker Non-Votes* 79,852,601 5,788,962 12,702,293 10,462,884”
CONSTELLIUM SE shareholders approved Re-appointment of Mr. John Ormerod as a director for a term of three years at the 2026-05-21 meeting.
“3. Re-appointment of Mr. John Ormerod as a director for a term of three years Voted For Voted Against Abstained Broker Non-Votes* 82,318,163 15,907,876 117,817 10,462,884”
CONSTELLIUM SE shareholders approved Appointment of Ms. Ingrid Joerg as a director for a term of three years at the 2026-05-21 meeting.
“2. Appointment of Ms. Ingrid Joerg as a director for a term of three years Voted For Voted Against Abstained Broker Non-Votes* 97,919,555 343,694 80,607 10,462,884”
CONSTELLIUM SE shareholders approved Ratification of the interim appointment of Ms. Ingrid Joerg as a director at the 2026-05-21 meeting.
“1. Ratification of the interim appointment of Ms. Ingrid Joerg as a director Voted For Voted Against Abstained Broker Non-Votes* 97,942,587 320,964 80,305 10,462,884”
CONSTELLIUM SE reported first quarter 2026 results: revenue $2.5 billion, net income $196 million. Guidance raised.
“reported results for the first quarter ended March 31, 2026. First quarter 2026 highlights: • Shipments of 370 thousand metric tons, down 1% compared to Q1 2025 • Revenue of $2.5 billion, up 24% compared to Q1 2025 • Net income of $196 million compared to net income of $38 million in Q1 2025 • Adjusted EBITDA of $359 million > Includes positive non-cash metal”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.